Compare NOV Inc. Common Stock (NOV) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NOV Inc. Common Stock vs 10X Genomics Inc — how do they compare? NOV Inc. Common Stock trades at $19.01 (market cap $6.77B), while 10X Genomics Inc trades at $81.19 (market cap $10.07B). The key difference: 10X Genomics Inc is the larger of the two by market cap, and NOV Inc. Common Stock pays a 1.9% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold NOV Inc. Common Stock for 1 Days and 10X Genomics Inc for 91 Days on average.
| NOV | TXG | |
|---|---|---|
Market Cap | $6.77B | $10.07B |
Volume | 3,592,724 | 5,657,286 |
Sector | Energy | Health |
52-Week High | $21.71 | $97.74 |
52-Week Low | $12.31 | $11.48 |
Typical Hold Time | 1 Days | 91 Days |
Enterprise Value | $7.93B | $9.59B |
Dividend Yield | 1.9% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
10x Genomics (TXG) trades at $82.37, up 8.24% over 24 hours, with a bearish technical signal and mixed analyst sentiment. The company reported a net loss of $43.54M in 2025, but revenue grew to $642.82M, and it has beaten EPS estimates for three consecutive quarters. Recent news highlights strong demand for its Atera platform and a patent victory, though profitability remains a challenge.
The outlook is cautiously optimistic, with growth potential from new product launches and spatial biology demand, but risks include persistent losses, high valuation multiples, and competitive pressures. The consensus price target is $74.30, below the current price, suggesting limited near-term upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NOV Inc. Common Stock
NOV provides technology, equipment, and services for energy production. Its offerings support drilling, well construction, and production across oil, gas, renewables, and emerging energy markets.
Read more on NOV →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
